Related Experiment Video
Updated: Dec 19, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Cough dynamics in adults receiving tuberculosis treatment
Gwenyth O Lee1,2, Germán Comina1, Gustavo Hernandez-Cordova1
1Department of Global Community Health and Behavioral Sciences, Tulane University, New Orleans, Louisiana, United States of America.
Measuring total time spent coughing, not frequency, is key for assessing tuberculosis treatment response. This objective method revealed increased coughing in patients with recurrent TB or diabetes, but not HIV or drug resistance.
Area of Science:
- Pulmonology
- Infectious Diseases
- Medical Technology
Background:
- Cough is a primary symptom and transmission route for tuberculosis (TB).
- Accurate cough measurement is crucial for assessing TB treatment effectiveness.
- Current methods for quantifying cough severity lack objective standardization.
Purpose of the Study:
- To identify the optimal method for measuring cough severity in pulmonary tuberculosis.
- To characterize changes in cough during the initial phase of TB therapy.
- To evaluate the utility of objective cough monitoring for treatment response assessment.
Main Methods:
- Prospective cohort study of 69 ambulatory adult pulmonary TB patients in Lima, Peru.
- Utilized a vibrometer for 4-hour involuntary cough recordings at pre-treatment and multiple follow-up points.
- Analyzed 358 recordings using a computer algorithm to quantify cough time, frequency, and power.
Main Results:
- Total time spent coughing (seconds per hour) was a superior predictor of microbiologic indicators compared to cough frequency or power.
- Patients with prior TB and those with co-morbid diabetes exhibited increased coughing.
- Cough characteristics did not significantly differ based on HIV co-infection or drug resistance status.
Conclusions:
- Objective monitoring of total time spent coughing provides a meaningful assessment of tuberculosis treatment response.
- Increased cough duration is associated with TB recurrence and diabetes co-morbidity.
- Time spent coughing is a reliable, objective biomarker for TB management, independent of HIV or drug resistance.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Other Pulmonary Disorders

